Revolution Medicines, Inc. (RVMD) FY2024 Q3 Statement of Cash Flows
2024-07-01 to 2024-09-30
Statement of Cash Flows
2024-07-01 to 2024-09-30
Swipe to see the full flow
Chart details
Revolution Medicines, Inc. cash flow reconciliation, Jul 1, 2024 through Sep 30, 2024
Cash flows for Jul 1, 2024 through Sep 30, 2024. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Jun 30, 2024. Ending cash: Sep 30, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Jun 30, 2024
- 278,744,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
- Operating activities
- negative 130,419,000 US dollars. Net cash used.
- Net loss
- negative 156,288,000 US dollars
- Loss on disposal of fixed assets
- 202,000 US dollars
- Amortization of intangible assets
- 268,000 US dollars
- Stock-based compensation expense
- 20,775,000 US dollars
- Depreciation
- 1,642,000 US dollars
- Change in fair value of warrant liabilities and contingent earn-out shares
- 1,269,000 US dollars
- Net amortization of premium or discount on marketable securities
- negative 9,593,000 US dollars
- Amortization of operating lease right-of-use asset
- 967,000 US dollars
- Impairment of assets
- 0 US dollars
- Accounts receivable
- 0 US dollars
- Prepaid expenses and other current assets
- 4,357,000 US dollars
- Accounts payable
- negative 2,788,000 US dollars
- Accrued expenses and other current liabilities
- 10,281,000 US dollars
- Deferred tax liability
- 0 US dollars
- Deferred revenue
- 0 US dollars
- Operating lease liability
- negative 705,000 US dollars
- Other noncurrent assets
- negative 1,881,000 US dollars
- Other noncurrent liabilities
- 1,075,000 US dollars
- Investing activities
- negative 21,469,000 US dollars. Net cash used.
- Purchases of marketable securities
- negative 364,877,000 US dollars
- Maturities of marketable securities
- 346,928,000 US dollars
- Purchases of property and equipment
- negative 3,520,000 US dollars
- Financing activities
- 77,294,000 US dollars. Net cash provided.
- Proceeds from issuance of common stock upon follow-on offering, net of issuance costs
- 0 US dollars
- Proceeds from issuance of common stock upon at-the-market offering, net of issuance costs
- 74,293,000 US dollars
- Proceeds from issuance of common stock under equity incentive plans
- 3,001,000 US dollars
- Proceeds from issuance of common stock related to employee stock purchase plan
- 0 US dollars
- Operating adjustment reconciliation
- 171,255,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing gross reconciliation
- 77,294,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 368,397,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- 0 US dollars
- Ending cash on Sep 30, 2024
- 204,150,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
- Cash sources and uses
- 356,038,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- negative 74,594,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
- Operating cash flow
- negative 130,419,000 US dollars. Operating cash flow used in the free cash flow calculation.
- Cash purchases of property, plant and equipment
- 3,520,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- negative 133,939,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$156.29M + net operating adjustments $25.87M = operating cash −$130.42M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 130,419,000 US dollars minus 3,520,000 US dollars equals negative 133,939,000 US dollars.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!